This is intended for Health Care Professionals only


English Pharmacy Board follow pharmacy roadmap

The first half of 2008 has seen a series of NHS policy developments that, when implemented, will change the way pharmacists practice in England.

Foremost of these is the White Paper, Pharmacy in England: Building on strengths – delivering the future, published in April, followed in July by Lord Darzi’s NHS Next Stage Review Final Report, and the workforce and primary and community care strategies.

Seen together, these provide a ‘roadmap’ for pharmacy over the next few years.

The English Pharmacy Board (EPB) represents all aspects of pharmacy practice in England as part of the Royal Pharmaceutical Society of Great Britain (RPSGB). In our remit to provide strategic leadership and support for pharmacy practice in England we have taken up the roadmap and are working closely with other pharmacy bodies to move forward in a co-ordinated way.

Many of the points made by the Darzi report in relation to pharmacy build upon elements of the Pharmacy White Paper.

Our four main ‘Darzi’ priorities are:

Staying Healthy

Local and convenient access means that pharmacy is central to meet the challenges of public health. There are opportunities for community pharmacy to build on current services such as obesity management, substance misuse, sexual health and smoking cessation and play a larger role in alcohol misuse. The recent switch of Azithromycin (for diagnosed Chlamydia infections), which becomes an over-the-counter product later this year, highlights the increasing use of pharmacists expertise.

Vascular health checks and the supporting public health campaign mentioned in Darzi are a big priority for the EPB. It will be beneficial for the community pharmacy network to be involved alongside other primary care professionals in a nationally organised service. 

Provision of support for patients with long-term conditions (LTCs) and care plans are areas in which pharmacists can add value to patient’s lives. While this was not a strong theme of Darzi it was clearly expressed in the White Paper where pharmacists will have a role in the planned care of LTC’s, particularly soon after diagnosis.

Streamlining local commissioning of community pharmacy services

The Primary and Community Care Strategy reiterates the commitment in the Pharmacy White Paper, to the growing role of community pharmacies in the treatment of minor ailments. The EPB believes that pharmacists should be providing a national minor ailments scheme, instead of relying on local commissioning decisions. Such a service could relieve GPs of 18% of all consultations, allowing them to focus on more complex illnesses. Some pharmacists can also contribute to more of the specialist care pathways moving into primary care settings.

The Board is also supporting the cross-recognition of accreditation for pharmacists providing local enhanced services between PCTs. This will lead to a more robust and flexible use of the pharmacy workforce and remove one of the barriers to commissioning.

Practice based commissioning is a continuing issue for community pharmacists who feel that local consortia are not yet in tune with world class commissioning principles and are missing the opportunity to commission services through pharmacies.

Primary Care Centres

Impact assessments must be carried out before the introduction of a primary care centre into a locality. The EPB supports the novel integration of services, but this may be achieved through more intelligent commissioning and not necessarily co-location. Patients and the public should be able to choose the healthcare services they need, be that visiting a pharmacy, polyclinic or GP surgery.  

Quality

The EPB welcomes the further embedding of quality principles at all levels and areas of the NHS and the commitment to evidence based research. This, along with the rewarding of innovation will play to the strengths of pharmacists who have for years been willing and able to take on new roles.

These developments relate to primary care, hospital pharmacy, academia and the pharmaceutical industry, as well as community pharmacy. A recurring theme of Darzi’s final report is that integrated working is the key for future success. The EPB agrees and is working with RPSGB staff and Council to put this into practice. 

Beth Taylor, Chair of the English Pharmacy Board

 

 

This is intended for Health Care Professionals only